Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 13/2022

Open Access 28.06.2022 | Image of the Month

Use of [11C]choline PET/CT for visualization of four hyperactive parathyroid glands in a patient with renal hyperparathyroidism

verfasst von: Matti Raitza, Aziz A. N. Alshalali, Andor W. J. M. Glaudemans, Rijk O. B. Gans, Riemer H. J. A. Slart

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 13/2022

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
This article is part of the Topical Collection on Endocrinology

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A 62-year-old male patient with a history of renal phosphaturia and slowly progressive chronic kidney disease (CKD) G4A2H presented with fatigue and hypercalcemia (2.7 mmol/L corrected for albumin) with an elevated parathyroid hormone (507 pg/mL).
He underwent a [11C]choline PET/low dose CT (20 min post-injection 440 MBq) to assess and differentiate more precisely the anatomical and functional presence of parathyroid hyperfunction.
The scan shows an intense focal [11C]choline uptake in the area of each of the four parathyroid glands (left MIP, see figure), with moderate higher levels in the upper two parathyroid glands (SUVmax 10.4) (middle column figure, and visible as well on the maximum intensity projection (MIP) image on the left side) in comparison to the lower two (SUVmax 8.7) (right-sided in figure). Based on this distribution pattern and the context of CKD, a diagnosis of secondary hyperparathyroidism with parathyroid hyperplasia was made, as well as tertiary (or primary, but less likely) hyperparathyroidism considering the high uptake in all parathyroid glands and the elevated serum calcium levels which is an unlikely finding in CKD. He was successfully treated with cinacalcet 60 mg bid.
Recently, radiolabeled choline, both in the form of [11C]choline and [18F]fluorocholine, has emerged as a highly specific and sensitive PET tracer for the identification of parathyroid adenomas [13]. [18F]fluorocholine has been studied much more extensively, because its longer half-life facilitates transport when no cyclotron is available on site. PET imaging is predominantly used to detect active parathyroid adenoma for the diagnosis of primary hyperparathyroidism, but the value of choline PET imaging for diagnosing secondary and tertiary hyperparathyroidism is largely unknown. Studies have shown that preoperative planning with nuclear imaging reduces the extent of surgical resection as well as the rate of surgical failure due to missing ectopic parathyroid glands [4, 5]. If in our case poor medical drug response should be noted, the three most hyperactive parathyroid glands would be selectively removed by the surgeon based on the choline PET imaging findings [6, 7]. Imaging directed based surgery reduces redo-surgeries and the perioperative complication rate will be very low [6]. Successful preoperative localization of enlarged and hyperfunctioning parathyroids increases cure rates [6].
[11C]choline or potential [18F]choline PET therefore appears to be a promising tracer for the differentiation between the primary, secondary, and tertiary hyperparathyroidism and may have consequences for treatment planning.

Declarations

An informed consent was given by the patient.

Conflict of interest

The authors declare no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

Literatur
Metadaten
Titel
Use of [11C]choline PET/CT for visualization of four hyperactive parathyroid glands in a patient with renal hyperparathyroidism
verfasst von
Matti Raitza
Aziz A. N. Alshalali
Andor W. J. M. Glaudemans
Rijk O. B. Gans
Riemer H. J. A. Slart
Publikationsdatum
28.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 13/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05885-8

Weitere Artikel der Ausgabe 13/2022

European Journal of Nuclear Medicine and Molecular Imaging 13/2022 Zur Ausgabe